James Kalabus

Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma

Max S. Topp, Johannes Duell, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2020 · 299 citations

Medicine, Hematology, Pharmacology +16

miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes

Andrew E. Bruno, Li Li, James Kalabus et al. · BMC Genomics · 2012 · 170 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy, in R/R multiple myeloma (MM) patients: Updated results of a first-in-human (FIH) phase I dose escalation study.

Max S. Topp, Johannes Duell, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2019 · 55 citations

Medicine, Hematology, Immunology +16

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

Vivek Subbiah, Sant P. Chawla, Anthony P. Conley et al. · Clinical Cancer Research · 2023 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13

Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors

Vanessa González-Covarrubias, Jianping Zhang, James Kalabus et al. · Drug Metabolism and Disposition · 2008 · 39 citations · Full text

Veterinary Medicine, Biochemistry, Genetics +13